A second recall of the blood pressure drug chlorthalidone is underway nationwide, this time covering 13,567 bottles of 25 mg tablets in 100-count bottles. India-based Inventia Healthcare Limited initiated the recall on Sept. 3 after the tablets failed dissolution specifications, and the FDA has classified it as a Class II recall, according to the FDA Enforcement Report.
The recall matters most to patients who checked their bottles in June and assumed they were in the clear. The September recall is separate from the June recall, so anyone who has refilled a chlorthalidone prescription since then may need to check again.
